Sepsis is defined as the systemic inflammatory response to infection. Phosp
holipase A(2) (PLA(2)) plays an important role in inflammation processes by
initiating the production of inflammatory mediators. The role of cytosolic
PLA (cPLA(2)) has not yet been identified in inflammatory and infectious d
isease clinical settings. The aim of the present research was to determine
whether cPLA(2) activity has a role during sepsis, Since neutrophil activat
ion has been documented during sepsis, these cells were chosen as a model t
o evaluate the function of cPLA(2) in this clinical setting. cPLA(2) was st
udied at 3 levels: activity, protein expression, and messenger RNA (mRNA),
Neutrophils from 32 septic patients with and without bacteremia were examin
ed. cPLA(2) activity was measured using labeled phosphatidyl choline vesicl
es as a substrate, and total PLA(2) was determined by the release of labele
d arachidonic acid from prelabeled cells. A significant increase in cPLA(2)
activity, protein expression, and total PLA(2) activity in neutrophils was
detected during sepsis, mRNA levels, detected by reverse transcriptase-pol
ymerase chain reaction, were significantly higher during sepsis, indicating
that the increase in the amount of cPLA(2) is regulated on the mRNA level.
The significant elevation of cPLA(2) activity and expression in neutrophil
s during sepsis suggests that this enzyme plays a major role in neutrophil
function In this clinical setting.